BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32300177)

  • 21. Next Generation Sequencing Reveals High Prevalence of BRCA1 and BRCA2 Variants of Unknown Significance in Early-Onset Breast Cancer in African American Women.
    Ricks-Santi L; McDonald JT; Gold B; Dean M; Thompson N; Abbas M; Wilson B; Kanaan Y; Naab TJ; Dunston G
    Ethn Dis; 2017; 27(2):169-178. PubMed ID: 28439188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population.
    Petrovics G; Price DK; Lou H; Chen Y; Garland L; Bass S; Jones K; Kohaar I; Ali A; Ravindranath L; Young D; Cullen J; Dorsey TH; Sesterhenn IA; Brassell SA; Rosner IL; Ross D; Dahut W; Ambs S; Figg WD; Srivastava S; Dean M
    Prostate Cancer Prostatic Dis; 2019 Sep; 22(3):406-410. PubMed ID: 30542053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inherited DNA-repair gene mutations in African American men with prostate cancer.
    Sartor O; Yang S; Ledet E; Moses M; Nicolosi P
    Oncotarget; 2020 Jan; 11(4):440-442. PubMed ID: 32064047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CYP3A43 Pro(340)Ala polymorphism and prostate cancer risk in African Americans and Caucasians.
    Stone A; Ratnasinghe LD; Emerson GL; Modali R; Lehman T; Runnells G; Carroll A; Carter W; Barnhart S; Rasheed AA; Greene G; Johnson DE; Ambrosone CB; Kadlubar FF; Lang NP
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1257-61. PubMed ID: 15894682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Racial parity in tumor burden, treatment choice and survival outcomes in men with prostate cancer in the VA healthcare system.
    Daskivich TJ; Kwan L; Dash A; Litwin MS
    Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):104-9. PubMed ID: 25582624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Germline mutation landscape of DNA damage repair genes in African Americans with prostate cancer highlights potentially targetable RAD genes.
    Kohaar I; Zhang X; Tan SH; Nousome D; Babcock K; Ravindranath L; Sukumar G; Mcgrath-Martinez E; Rosenberger J; Alba C; Ali A; Young D; Chen Y; Cullen J; Rosner IL; Sesterhenn IA; Dobi A; Chesnut G; Turner C; Dalgard C; Wilkerson MD; Pollard HB; Srivastava S; Petrovics G
    Nat Commun; 2022 Mar; 13(1):1361. PubMed ID: 35292633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death.
    Na R; Zheng SL; Han M; Yu H; Jiang D; Shah S; Ewing CM; Zhang L; Novakovic K; Petkewicz J; Gulukota K; Helseth DL; Quinn M; Humphries E; Wiley KE; Isaacs SD; Wu Y; Liu X; Zhang N; Wang CH; Khandekar J; Hulick PJ; Shevrin DH; Cooney KA; Shen Z; Partin AW; Carter HB; Carducci MA; Eisenberger MA; Denmeade SR; McGuire M; Walsh PC; Helfand BT; Brendler CB; Ding Q; Xu J; Isaacs WB
    Eur Urol; 2017 May; 71(5):740-747. PubMed ID: 27989354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a novel germline missense mutation of the androgen receptor in African American men with familial prostate cancer.
    Hu SY; Liu T; Liu ZZ; Ledet E; Velasco-Gonzalez C; Mandal DM; Koochekpour S
    Asian J Androl; 2010 May; 12(3):336-43. PubMed ID: 20173765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between germline variation in the FHIT gene and prostate cancer in Caucasians and African Americans.
    Levin AM; Ray AM; Zuhlke KA; Douglas JA; Cooney KA
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1294-7. PubMed ID: 17548701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Counting alleles in single lesions of prostate tumors from ethnically diverse patients.
    Morikawa A; Varma V; Gillespie TW; Lyles RH; Goodman M; Bostick RM; Mandel JS; Zhou W
    Prostate; 2008 Feb; 68(3):231-40. PubMed ID: 18092351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men.
    Rennert H; Zeigler-Johnson CM; Addya K; Finley MJ; Walker AH; Spangler E; Leonard DG; Wein A; Malkowicz SB; Rebbeck TR
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):949-57. PubMed ID: 15824169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of men.
    Beuten J; Gelfond JA; Franke JL; Shook S; Johnson-Pais TL; Thompson IM; Leach RJ
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):588-99. PubMed ID: 20086112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate cancer screening in high-risk men: African American Hereditary Prostate Cancer Study Network.
    Weinrich SP
    Cancer; 2006 Feb; 106(4):796-803. PubMed ID: 16411222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Racial differences in clinical and pathological associations with PhIP-DNA adducts in prostate.
    Tang D; Liu JJ; Bock CH; Neslund-Dudas C; Rundle A; Savera AT; Yang JJ; Nock NL; Rybicki BA
    Int J Cancer; 2007 Sep; 121(6):1319-24. PubMed ID: 17487839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study.
    Mechanic LE; Millikan RC; Player J; de Cotret AR; Winkel S; Worley K; Heard K; Heard K; Tse CK; Keku T
    Carcinogenesis; 2006 Jul; 27(7):1377-85. PubMed ID: 16399771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
    Gao X; Porter AT; Honn KV
    Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathologic analysis of pancreatic adenocarcinoma in African Americans and Caucasians.
    Pernick NL; Sarkar FH; Philip PA; Arlauskas P; Shields AF; Vaitkevicius VK; Dugan MC; Adsay NV
    Pancreas; 2003 Jan; 26(1):28-32. PubMed ID: 12499914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA Repair Pathways and Their Association With Lethal Prostate Cancer in African American and European American Men.
    Plym A; DiĆ³ssy M; Szallasi Z; Sartor O; Silberstein J; Powell IJ; Rebbeck TR; Penney KL; Mucci LA; Pomerantz MM; Kibel AS
    JNCI Cancer Spectr; 2022 Feb; 6(1):. PubMed ID: 35079693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence.
    Keenan T; Moy B; Mroz EA; Ross K; Niemierko A; Rocco JW; Isakoff S; Ellisen LW; Bardia A
    J Clin Oncol; 2015 Nov; 33(31):3621-7. PubMed ID: 26371147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex steroid hormones in young manhood and the risk of subsequent prostate cancer: a longitudinal study in African-Americans and Caucasians (United States).
    Tsai CJ; Cohn BA; Cirillo PM; Feldman D; Stanczyk FZ; Whittemore AS
    Cancer Causes Control; 2006 Dec; 17(10):1237-44. PubMed ID: 17111254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.